China Biologic’s predecessor, Shandong Institute, was established in 1971. The Shandong Institute is the research arm established by and directly administrated by the Shandong Provincial Health Department. It was the only entity approved for the research, development, and production of biological and plasma based biopharmaceutical products in Shandong province, the second largest province in China (by population). Since 1998, it promoted Good Manufacturing Practices management in the production process of blood products and became one of the first blood product manufacturing enterprises to obtain Good Manufacturing Practices Certification in China. In 2002, the Shandong Institute transferred all of its operations and the licenses necessary to carry on its business to the China Biologic’s subsidiary, Shandong Taibang.
In 2005 and 2006, Shandong Taibang was awarded the advanced high-tech enterprise certification by the Department of Science and Technology of Shandong Province and the Ministry of Science and Technology of China. In 2007, it was admitted as a member of the Shandong Institute of Medicine and awarded the "Advanced Enterprise" accolade by the Shandong Blood Center.
In April 2009, China Biologic acquired Chongqing Dalin Biologic Technologies Co., Ltd. (“Dalin”). Dalin held a 54% majority ownership in its operating subsidiary, Qianfeng Biological Products Co., Ltd. (“Qianfeng”), one of the largest plasma-based biopharmaceutical companies in China, located in Guiyang, Guizhou province.
Our R&D Philosophy: We believe success comes from developing a pipeline of new products that will be in high demand to help save lives. In plasma processing, success primarily derived from product and process improvements that increase product safety and maximize the yield per unit volume of plasma.
Our research and development efforts are focused on:
Our research center is adjacent to our production factory in Tai'an, Shandong province. The research center is equipped with specialized equipment, including advanced testing and analysis equipment (for example, an atomic absorptiometer), fully automated blood coagulation analyzers, high performance liquid chromatographs, gas chromatographs, radioimmunoassay analyzers, ultraviolet-visible spectrophotometers, and protein chromatographs. Most of our equipment has been imported from the U.S.A., Japan, Italy, Germany, and Australia. Our R&D department is staffed with about 30 researchers who have advanced degrees in medicine, pharmacy, biology, or biochemistry.